Charles Swingland
Direktor/Vorstandsmitglied bei Sensyne Health Holdings Ltd.
Ursprung des Netzwerks ersten Grades von Charles Swingland
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 22 | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK
12
| Subsidiary | Medical Specialties | 12 |
Sensyne Health Holdings Ltd.
 Sensyne Health Holdings Ltd. Electronic Production EquipmentElectronic Technology Sensyne Health Holdings Ltd. provides wireless charging technology. It focuses on developing wireless energy devices and wireless sensor networks. The company was founded by Elspeth Drayson, Paul R. Drayson and Manuel Pinuela in April 2014 and is headquartered in London, the United Kingodm.
6
| Holding Company | Electronic Production Equipment | 6 |
Adiga Life Sciences, Inc.
 Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada.
3
| Private Company | Pharmaceuticals: Major | 3 |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Other | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Charles Swingland
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Chief Operating Officer | |
| VERNALIS | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chairman Director/Board Member Director/Board Member Consultant / Advisor | |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Chief Executive Officer Director/Board Member General Counsel Chief Tech/Sci/R&D Officer | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Graduate Degree Director/Board Member Graduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of London | College/University | Graduate Degree Doctorate Degree | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| King's College London | College/University | Doctorate Degree | |
Association of Chartered Certified Accountants
 Association of Chartered Certified Accountants Miscellaneous Commercial ServicesCommercial Services The Association of Chartered Certified Accountants (ACCA) is a professional body for accountants. The non-profit company is based in Glasgow, UK, and has subsidiaries in Mauritius, United Kingdom, and Hong Kong. The British company offers a program called ALP-C, which approves learning materials from high-quality content providers to support studying towards ACCA's qualification. The role of the CFO is evolving beyond finance to include reporting on value-centric aspects of their operations, as companies move towards sustainable practices. The CEO of the company is Helen Joanna Brand. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman Chairman | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member | |
| Allergy & Clinical Immunology Associates, Inc. | Corporate Officer/Principal President | ||
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman Chief Operating Officer | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder Founder | |
Eusa Pharma International Ltd.
 Eusa Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Eusa Pharma International Ltd. is a Gibraltar specialty biopharmaceutical company that identifies, develops, and commercializes pharmaceutical products. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Neuro Foundation | Investment Trusts/Mutual Funds | Chairman | |
Circassia Pharma Ltd.
 Circassia Pharma Ltd. Medical/Nursing ServicesHealth Services Circassia Pharma Ltd. is a biopharmaceutical company, which engages as a subsidiary of Circassia Pharmaceuticals plc. It focuses on the research and development of respiratory disease and allergy products. The company was founded on October 26, 2007 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| 3G Advisors LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
Drayson Technologies (Europe) Ltd.
 Drayson Technologies (Europe) Ltd. Information Technology ServicesTechnology Services Founded in 2013, Drayson Technologies (Europe) Ltd. is a healthcare Internet of British things company. Part of Sensyne Health Holdings Ltd., the company is based in London, UK. | Information Technology Services | Director/Board Member Director/Board Member | |
JNE Invest AB
 JNE Invest AB Investment ManagersFinance JNE Invest AB (JNE Invest) is a venture capital firm founded in 2015 by Niklas Norén. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
IWH UK Midco Ltd.
 IWH UK Midco Ltd. Financial ConglomeratesFinance IWH UK Midco Ltd. operates as an investment holding firm. The company was founded on September 4, 2017 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
IWH UK Finco Ltd.
 IWH UK Finco Ltd. Financial ConglomeratesFinance IWH UK Finco Ltd. functions as an investment holding private company. The company is based in London, UK. and has subsidiaries in United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Sensyne Health Group Ltd.
 Sensyne Health Group Ltd. Miscellaneous Commercial ServicesCommercial Services Sensyne Health Group Ltd. provides professional, scientific, and technical services. The private company was founded in 2018 and is based in Oxford, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
IWH UK Holdco Ltd.
 IWH UK Holdco Ltd. Miscellaneous Commercial ServicesCommercial Services IWH UK Holdco Ltd. is a private company that provides business services. The company is based in London, UK. The British company was founded in 2017. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Drayson Holdco 2 Ltd. | Chairman | ||
Brenn Distribution, Inc.
 Brenn Distribution, Inc. Pharmaceuticals: MajorHealth Technology Brenn Distribution, Inc. develops and distributes generic medicines. The company was founded on June 17, 1986 and is headquartered in Huntsville, AL. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistik
International
| Vereinigtes Königreich | 29 |
| Vereinigte Staaten | 16 |
| Schweden | 3 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 24 |
| Commercial Services | 10 |
| Consumer Services | 6 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 233 |
| Corporate Officer/Principal | 102 |
| Chairman | 64 |
| Independent Dir/Board Member | 50 |
| Chief Executive Officer | 40 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Noble | 39 |
| Cathrin Petty | 29 |
| Marvin Samson | 28 |
| Michel Gréco | 28 |
| Paul Edick | 27 |
| Clive Dix | 24 |
| Francesco Granata | 24 |
| Brenda Reynolds | 21 |
| Lota Zoth | 20 |
| Timothy Corn | 20 |
| Paul Rudd Drayson | 20 |
| Jean-Jacques Garaud | 17 |
| Mustapha Bakali | 16 |
| Larry Ellberger | 16 |
| Steven Harris | 16 |
- Börse
- Insiders
- Charles Swingland
- Unternehmensverbindungen
